A61B5/4094

Device and method for examining a phase distribution used to determine a pathological interaction between different areas of the brain

A device for examining a pathological interaction between different brain areas, including a stimulation unit, which administers identical stimuli to a patient in a sequential manner, wherein the stimuli stimulate neurons of the patient in the brain areas to be examined, a measuring unit for recording measurement signals that represent a neural activity of the stimulated neurons, and a control and analysis unit for controlling the stimulation unit and for analyzing the measurement signals. The control and analysis unit transforms the measurement signals into the complex plane, examines the distribution of the phases of stimuli of the measurement signals absorbed by the measuring unit in response to the stimuli delivered to the patient, and determines the probability, with which the phase distribution differs from a uniform distribution, in order to ascertain whether a pathological interaction between the brain areas exists.

BIOFEEDBACK SYSTEM

A biofeedback system for headache patients comprises: a sensor system (2) for obtaining and transmitting data indicative of a plurality of physiological parameters of the patient, a personal computing device (4) arranged to receive data from the sensor system (2) and to interact with the patient via a user interface of the personal computing device (4), and a computer-implemented biofeedback agent (6). The sensor system (2) is configured for measurement of the physiological parameters of the patient, wherein the physiological parameters include at least two of muscle tension, body temperature, heart rate and heart rate variability. The personal computing device (4) together with the biofeedback agent (6) are configured to carry out the following steps: obtain data indicative of the physiological parameters from the sensor system (2); instruct the patient to control the physiological parameters; determine baseline levels for each of the physiological parameters; derive a score for each of the physiological parameters relative to the baseline levels, wherein the score increases in reaction to control of the respective physiological parameter; and use a weighting system to determine a weighting for the score associated with each of the physiological parameters and present a total score to the patient via the user interface, the total score consisting of a combination of the weighted scores, wherein the weighting system gives a higher weighting to the score for the physiological parameter that the patient most successfully controls and a lower weighting to the score for the physiological parameter that the patient least successfully controls.

DISEASE-CONDITION ASSESSMENT DEVICE, DISEASE-CONDITION ASSESSMENT METHOD, PROGRAM FOR DISEASE-CONDITION ASSESSMENT DEVICE, AND DISEASE-CONDITION ASSESSMENT SYSTEM

Provided are a disease-condition assessment device for being capable of assessing an epileptic condition of a subject, a disease-condition assessment method, a program for disease-condition assessment device, and a disease-condition assessment system. The gaze data indicating a subject's gazing point measured when the subject is driving a vehicle is acquired, the driving-characteristic data indicating driving characteristics of the subject for the vehicle is acquired), and the epileptic condition of the subject is assessed depending on the relationship between the gaze data and the driving-characteristic data.

DEVICE FOR EFFECTIVE NON-INVASIVE DESYNCHRONIZING NEUROSTIMULATION
20170333711 · 2017-11-23 ·

A device that suppresses a pathological synchronous and oscillatory neuron activity, and includes a non-invasive stimulation for stimulation, using stimuli, of neurons in the patient's brain and/or spinal cord, where those neurons are showing pathologically synchronous and oscillatory neuron activity, and the stimuli are designed to suppress are this activity when administered to the patient. Moreover, a measuring unit records measurement signals reflecting the neuron activity of the stimulated neurons and a control and analysis unit controls the stimulation unit to administer stimuli, check the success of stimulation based on the measurement, and, if the stimulation success is not sufficient, insert one or more stimulation breaks in the application of the stimuli or extend one or more stimulation breaks, where no stimuli that could suppress the pathological synchronous and oscillatory neuron activity are applied during the stimulation breaks.

SYSTEM AND METHOD FOR DETECTION OF ONSET AND ICTAL PHASES OF AN EPILEPSY SEIZURE
20230172528 · 2023-06-08 ·

A system for detection of onset and ictal phases of an epileptic seizure comprises at least one motion sensor, at least one intermediate device and a sensing data interpretation device, embedded with an application program that, after execution, detects onset and ictal phases of an epileptic seizure, and configured to mark a feature or a reference on, or normalize sensing data of a motion sensing data file, wherein the reference comprises at least one of a phase of an epileptic seizure, a sensor position and a sensing time.

Correlating brain signal to intentional and unintentional changes in brain state
09820663 · 2017-11-21 · ·

Methods of analysis to extract and assess brain data collected from subject animals, including humans, to detect intentional and unintentional brain activity and other unexpected signals are disclosed. These signals are correlated to higher cognitive brain functions or unintended, potentially adverse events, such as a stroke or seizure, and to translation of those signals into defined trigger events or tasks.

Treatment of an Epilepsy-Associated Disorder

The present invention relates to an apparatus for the treatment of an epilepsy-associated disorder in a living being and to a method for the treatment of an epilepsy-associated disorder in a living being.

WEARABLE HEALTH MONITORING DEVICE

A wearable health monitoring device includes a band configured to attach the wearable health monitoring device to a user's body; a VOC detection device configured to collect and analyze volatile organic compounds given off from the user's skin to identify specific health-indicative volatile organic compounds indicative of a health condition; and a biomarker sensor configured to detect a biomarker of the user.

DETECTING, ASSESSING AND MANAGING A RISK OF DEATH IN EPILEPSY
20220354438 · 2022-11-10 ·

A method for determining and responding in real-time to an increased risk of death relating to a patient with epilepsy is provided. The method includes receiving cardiac data and determining a cardiac index based upon the cardiac data. The method includes determining an increased risk of death associated with epilepsy if the indices are extreme, issuing a warning of the increased risk of death and logging information related to the increased risk of death. Also presented is a second method for determining and responding in real-time to an increased risk of death relating to a patient with epilepsy comprising receiving at least one of arousal data, responsiveness data or awareness data and determining an arousal index, a responsiveness index or an awareness index, where the indices are based on arousal data, responsiveness data or awareness data respectively. The second method includes determining an increased risk of death related to epilepsy if indices are extreme values, issuing a warning of the increased risk of death and logging information related to the increased risk of death. A computer readable program storage device is also provided. Also provided is a method for receiving body data, determining a cardiac, an arousal, a responsiveness, or a kinetic index, determining an increased or increasing risk of death over a first time window relating to a patient with epilepsy and issuing a warning and logging relevant information.

Autonomous vehicle operating status assessment

Methods and systems for monitoring use, determining risk, and pricing insurance policies for a vehicle having one or more autonomous or semi-autonomous operation features are provided. According to certain aspects, a computer-implemented method for real-time determination of the status of autonomous operation features of an autonomous or semi-autonomous vehicle may be provided. With the customer's permission, the operation of the autonomous or semi-autonomous vehicle may be monitored to obtain operating data from one or more autonomous operation features. An operating status of the autonomous features may be determined based upon the operating data. After which, a change in the operating status of the autonomous features may be identified, and a report containing information regarding the change in the operating status of the autonomous features may be generated. Insurance discounts may be provided to risk averse customers that maintain their autonomous vehicles, and associated accident avoidance functionality, in good working condition.